InvestorsHub Logo

GS1

Followers 115
Posts 4767
Boards Moderated 0
Alias Born 07/11/2010

GS1

Re: JPetroInc post# 110354

Tuesday, 12/16/2014 12:04:57 AM

Tuesday, December 16, 2014 12:04:57 AM

Post# of 130502
I don't have any reason to believe otherwise.

Profitable biotech companies trade anywhere between 20-70 times its valuation.Regenerative medicine hot biotech sector nowadays especially Alzheimers. A year from now when Lympro reach its true potential it is possible that AMBS could trade in that range. All depends on Lympro sales which I expect to be significantly higher. We shall see soon..